Hints and tips:
Related Special Reports
...He set aside £520mn in his November Autumn Statement to “build resilience for future health emergencies and capitalise on the UK’s R&D strengths”....
...Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease....
...Among the notable patent expiries this decade is BMS and Pfizer’s Eliquis blood clot treatment from 2026. BMS will also lose US exclusivity on its lung cancer treatment Opdivo in 2028....
...Back at Kanalhuset, pudding is a pineapple and rum-infused cream with a blood-orange sorbet on a bed of caramelised oats....
...Research published last month in the journal Science, and led by Professor Onur Boyman of Zurich university, reported that changes in blood protein had been found in people suffering from long Covid, offering...
...“But it has been a polarising debate, given the potential impact of reforms on R&D budgets and what that means for global innovation.”...
...Mounjaro is one of a new class of drugs known as GLP-1 agonists that work by lowering blood sugar levels after eating and suppressing appetite....
...A US judge found in January that a blood oxygen sensor on recent Apple Watch models infringed patents owned by medical device maker Masimo....
...After making good use of a bondage swing and some fake blood, she set the stage for the headline act....
...“There will be a small number of winners, a lot of losers and a lot of blood on the floor.”...
...“I was blindsided and horrified . . . five years of blood, sweat and tears from me and so many employees, driving towards something that I thought was a beautiful force for good, had turned out to be so...
...The development of pre- and probiotic foods and supplements, such as yoghurt, which promote the growth of healthy bacteria in the gut, drove the first wave of microbiome R&D 20 years ago....
...Even so, Tate & Lyle has refocused its investment and R&D on stevia in response to client demand....
...Eli Lilly last year scrapped development of a drug targeting blood cancers. Bristol Myers Squibb has warned of similar moves....
...Mene Pangalos, head of biopharmaceuticals R&D at AstraZeneca, said: “We are moving in a big way into cell therapies outside oncology, where they have been remarkably effective for treating some cancers.”...
...But she started taking electrolytes and then went for a traditional blood screen. And her, like, sodium levels were dangerous....
...Romance is in rude health throughout Desire; tender sentiments appear alongside messy glamour, lust and mystique (including the alt-R&B throb of “Bunny Is a Rider”, originally released in 2021)....
...Meanwhile, our share of the global pharmaceutical R&D market is declining....
...Recent trials to treat rheumatoid arthritis and blood cancer have been disappointing. GSK might be better off buying platforms rather than trying to build from a subscale base....
...Cliffhanger falls under the mid-budget standalone adult film (rated R for explicit language and violence) that everyone keeps lamenting no longer exists, despite Liam Neeson, Denzel Washington, Gerard Butler...
...Now comes House of the Dragon, a prequel based on George RR Martin’s 2018 novel Fire & Blood, set 170 years before the events depicted in Game of Thrones....
...We have brown bread, onion, tomato, fresh squeezed orange juice: a blend of blood oranges and tangerines....
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
...How far do we crave flesh-and-blood contact – or paper and ink? The recent experience of H&R Block, a gigantic American tax adviser, is striking in this respect....
...Some Chinese commentators have noted that Putin did emerge victorious quickly and with little blood spilt....
International Edition